Navigation Links
Stop-Smoking Drug May Also Curb Problem Drinking
Date:2/15/2012

By Denise Mann
HealthDay Reporter

WEDNESDAY, Feb. 15 (HealthDay News) -- The quit-smoking drug Chantix may also help problem drinkers cut their alcohol consumption, a small new study suggests.

Exactly how this drug curbs drinking is not fully understood, but its use may increase blood pressure, heart rate and feelings of sadness and nausea, thereby blunting the pleasurable effects of alcohol, the researchers said.

"Chantix might reduce alcohol consumption by reducing overall enjoyment of the alcohol drinking experience," said study author Emma Childs, a research associate at the University of Chicago.

"Chantix increased the unpleasant effects of alcohol, for example feeling drowsy and irritable, [and] participants also reported that they didn't like the alcohol effects as much," Childs said.

Approved to help smokers quit in 2006, Chantix (varenicline) has its share of potential side effects. In July 2009, the U.S. Food and Drug Administration mandated that Chantix carry a "black box" warning about the potential risks of depression and suicidal thoughts. Recently, the drug was linked to a small but significant risk of heart attack and stroke among people with pre-existing heart disease. Chantix costs roughly $3 per pill.

The results of the new study were released online in Alcoholism: Clinical & Experimental Research prior to publication in the May print issue.

The study included 15 healthy participants who took part in six sessions. They received a 2-mg dose of Chantix and an inactive placebo, followed three hours later by a beverage containing either a placebo, a low dose of alcohol, or a high dose of alcohol.

Before and after the sessions, the researchers asked the participants about their mood, tested visual ability and measured physiological responses such as blood pressure and heart rate.

The participants found the Chantix-booze combination increased the unpleas
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Stop-Smoking Drug Chantix Ups Risk of Heart Problems: Study
2. Back Problems May Cut Into Retirement Savings
3. C-Sections Might Put Preemies at Risk for Breathing Problems
4. Cognitive problems common among non-demented elderly
5. Child Abuse, Neglect a Major Public Health Problem: CDC
6. People who retire early due to back problems face long-term financial disadvantage
7. Scientific plagiarism: A growing problem in an era of shrinking research funding
8. Hip Fracture Patients Often Have Other Health Problems
9. Many Head and Neck Cancer Survivors Face Eating Problems
10. Antidepressants While Pregnant Linked to Slight Risk of Lung Problem in Babies
11. Autism Gastro Problems May Be Linked to Gut Bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stop-Smoking Drug May Also Curb Problem Drinking
(Date:7/23/2014)... July 23, 2014 The European Vitamins ... Europe with analysis and projection of revenue. The market ... million in 2012 to $1,202.08 million by 2018, at ... Browse through the TOC of the European Vitamins Market ... provided. This also provides a glimpse of the segmentation ...
(Date:7/23/2014)... European Bio fertilizers Market Report defines and segments the ... of revenue. The bio fertilizers market in Europe is ... 2012 to $4,582.2 million by 2017, at a CAGR ... the TOC of the European Bio fertilizers Market report, ... , http://www.micromarketmonitor.com/market/europe-bio-fertilizer-4637178345.html , The bio fertilizers ...
(Date:7/23/2014)... (July 23, 2014) Statins, a class of drugs ... patient,s risk of developing Barrett,s esophagus, according to a ... , the official journal of the American Gastroenterological Association. ... with statin use. , "Patients who received statins had ... Barrett,s esophagus compared to non-users," said study author Hashem ...
(Date:7/23/2014)... to a new market research report of "Semiconductor (Silicon) ... IP), Design Architecture (Hard IP, Soft IP), Processor Type ... & Analysis to 2013 - 2020", the semiconductor (silicon) ... of 12.6% from 2014 to 2020 and reach $5.63 ... data tables with 60 figures spread through 337 pages ...
(Date:7/23/2014)... identified three genetic changes linked to an increased risk ... investigators, was published online July 20 in Nature ... the most common malignancies among women worldwide, most studies ... focused on women of European ancestry. , Given the ... Asian women and those of European ancestry, the investigators ...
Breaking Medicine News(10 mins):Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 2Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 3Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 4Health News:Statin use decreases the risk of Barrett's esophagus 2Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 5Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 6Health News:Vanderbilt-led study identifies genes linked to breast cancer in East Asian women 2
... has found that alcohol does not kill off brain ... Queensland Brain Institute director Professor Perry Bartlett, the notion ... function similar to a napalm bomb strike, is erroneous. ... the world's top neuroscientists, claims that there is no ...
... Anderson Cancer Center have found in pre-clinical trials that ... in pancreatic cancer that shrinks or eradicates tumours, inhibits ... ,"This vehicle, or vector, is so targeted and ... used for therapy and perhaps for imaging," notes senior ...
... Residents in the United Kingdom would have to consider ... want to enjoy a pollution-free and greener future, a ... has said. ,According to the report, the ... operated cars and avoiding affordable flights. ...
... stroke patients practise daily tasks with impaired limbs, are ... Administration has approved a new robotic device called the Myomo ... arms. It is to hit the market shortly. ... weak electrical activity in patients arm muscles and providing just ...
... a new gene mutation that is associated with frontotemporal ... known as Prick's disease . ,Frontotemporal ... brain that control behaviour and language. Language problems, personality ... ,Unlike Alzheimer's disease, this Frontotemporal dementia does ...
... many of the genetic bits and pieces that drive ... disadvantages to humans or other animals. ,Nicholas ... Medicine said that the Hopkins experiments demonstrate that one ... DNA repeat elements that make up over 40 percent ...
Cached Medicine News:Health News:Gene Therapy Eradicates Pancreatic Cancer in Mice 2Health News:Brits Need to Change Lifestyle to Have a Greener Future: Report 2Health News:FDA Approve S Robotic Device to Help Stroke Patients 2Health News:FDA Approve S Robotic Device to Help Stroke Patients 3Health News:FDA Approve S Robotic Device to Help Stroke Patients 4Health News:Scientists Identify New Genetic Mutation Behind Common Dementia 2Health News:Completely Neutral Evolutionary Changes Helped Shape Our Genome 2
(Date:7/23/2014)... YORK , July 23, 2014  Dompe, a leader ... rare diseases, announces that rhNGF (Recombinant Human Nerve Growth Factor) ... Food and Drug Administration (FDA). The candidate ... as an orphan drug for the treatment of neurotrophic keratitis, ... 5,000 people 1 and is currently without a cure. ...
(Date:7/23/2014)... July 23, 2014  ArmaGen, a privately held ... treat severe neurological disorders, announced today that it ... agreement with Shire plc to develop AGT-182, an ... of both the central nervous system (CNS) and ... as MPS II, Hunter syndrome is a rare, ...
(Date:7/23/2014)... July 23, 2014 ... Arbeiten für Sadara Chemical Company (Sadara) erhalten ... System innerhalb des integrierten Chemiekomplexes von Sadara ... additional scope im Wert von mehreren Millionen ... Vertrags dar, dessen Wert sich ebenfalls auf ...
Breaking Medicine Technology:Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 2Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 3Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 4ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 3Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 2Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 3Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 4
... Oct. 26 Sequoia Pharmaceuticals presented,positive results today ... protease inhibitor (PI). One study based on an ... of SPI-256 with HIV protease,provides a rationale for ... The second study conducted in healthy volunteers demonstrates,that ...
... Results of two Phase III studies affirmed the ... 25 Data from two Phase III studies,showed ... painful effects,of rheumatoid arthritis (RA) achieved significant improvements ... alone or in combination,with methotrexate compared with methotrexate ...
Cached Medicine Technology:Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor 2Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor 3Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor 4ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 2ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 3ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 4ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 5ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 6
A system for all indications, can be used with the OrthoPilot surgical navigation system....
Electric high speed system....
The humidity chamber maintains a moist environment during immunostaining procedures as well as other laboratory procedures requiring controlled incubation steps....
Compressor-cooled plate used to keep blocks cold while sectioning....
Medicine Products: